| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.33(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,422 |
| 52
Week Range: |
$6.13 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
| Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
2 |
4 |
7 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mckenna Mark C. |
President, Salix |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,221 |
35,162 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,610 |
69,031 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,221 |
117,018 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
21,310 |
173,950 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
21,310 |
69,320 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
62,915 |
289,781 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2019-01-08 |
4 |
D |
$21.25 |
$73,228 |
D/D |
(3,446) |
48,010 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2019-01-08 |
4 |
D |
$21.25 |
$36,040 |
D/D |
(1,696) |
61,421 |
|
- |
|
| Mckenna Mark C. |
President, Salix |
• • – |
2019-01-08 |
4 |
D |
$21.25 |
$25,288 |
D/D |
(1,190) |
19,941 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2019-01-08 |
4 |
D |
$21.25 |
$46,091 |
D/D |
(2,169) |
38,225 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2019-01-08 |
4 |
D |
$21.25 |
$36,593 |
D/D |
(1,722) |
152,640 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2019-01-03 |
4 |
D |
$18.47 |
$245,854 |
D/D |
(13,311) |
101,797 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2018-12-31 |
4 |
A |
$18.47 |
$31,233 |
D/D |
1,691 |
262,635 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2018-12-31 |
4 |
A |
$18.47 |
$40,819 |
D/D |
2,210 |
77,377 |
|
- |
|
| Paulson John |
Director |
• • – |
2018-12-31 |
4 |
A |
$18.47 |
$27,483 |
D/D |
1,488 |
40,699 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2018-12-31 |
4 |
A |
$18.47 |
$31,695 |
D/D |
1,716 |
73,165 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2018-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
25,440 |
154,362 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2018-12-14 |
4 |
B |
$22.96 |
$584,018 |
D/D |
25,440 |
128,922 |
2.74 |
- |
|
| Von Eschenbach Andrew C. |
Director |
• • – |
2018-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,832 |
6,832 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2018-10-16 |
4 |
AS |
$25.50 |
$115,821 |
D/D |
(4,542) |
51,456 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2018-10-15 |
4 |
AS |
$24.83 |
$382,481 |
D/D |
(15,404) |
55,998 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2018-09-28 |
4 |
A |
$25.67 |
$31,240 |
D/D |
1,217 |
260,944 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2018-09-28 |
4 |
A |
$25.67 |
$31,240 |
D/D |
1,217 |
71,449 |
|
- |
|
| Paulson John |
Director |
• • – |
2018-09-28 |
4 |
A |
$25.67 |
$27,493 |
D/D |
1,071 |
39,211 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2018-09-28 |
4 |
A |
$25.67 |
$37,478 |
D/D |
1,460 |
75,167 |
|
- |
|
1058 Records found
|
|
Page 17 of 43 |
|
|
0.27 (4.29%) 
